HAVCR2 and neoplasm: In mouse models, the immunosuppressive or anti-tumor roles of IL-35 have been linked to its ability to induce the expression of IL-10 and the immune checkpoints LAG3, TIM3, and PD1 in T cells, leading to T cell exhaustion and decreased anti-tumor immunity (8).